Filtros de búsqueda

Lista de obras de Maddalena Barba

"Triple positive" early breast cancer: an observational multicenter retrospective analysis of outcome.

scientific article published on 18 February 2016

A Real-World Multicentre Retrospective Study of Paclitaxel-Bevacizumab and Maintenance Therapy as First-Line for HER2-Negative Metastatic Breast Cancer.

artículo científico publicado en 2016

A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study

artículo científico publicado en 2018

A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real-world experience

artículo científico publicado en 2017

An instrument to assess quality of life in relation to nutrition: item generation, item reduction and initial validation

artículo científico publicado en 2010

Analysis of the ATR-Chk1 and ATM-Chk2 pathways in male breast cancer revealed the prognostic significance of ATR expression. ⬇️

artículo científico publicado en 2017

Analysis of the hippo transducers TAZ and YAP in cervical cancer and its microenvironment.

artículo científico publicado en 2016

Androgen receptor and antiandrogen therapy in male breast cancer ⬇️

artículo científico

Anthropometric, metabolic and molecular determinants of human epidermal growth factor receptor 2 expression in luminal B breast cancer

artículo científico publicado en 2015

Antiandrogen therapy in metastatic male breast cancer: results from an updated analysis in an expanded case series.

artículo científico publicado en 2014

Anticoagulation for patients with cancer and central venous catheters

artículo científico publicado en 2011

Anticoagulation for patients with cancer and central venous catheters

artículo científico publicado en 2011

Anticoagulation for people with cancer and central venous catheters

artículo científico publicado en 2014

Anticoagulation for people with cancer and central venous catheters

artículo científico publicado en 2018

Anticoagulation for perioperative thromboprophylaxis in people with cancer

artículo científico publicado en 2018

Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer

artículo científico publicado en 2014

Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer

artículo científico publicado en 2011

Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer

artículo científico publicado en 2011

Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer

artículo científico publicado en 2011

Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer

artículo científico publicado en 2008

Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer: a systematic review

artículo científico publicado en 2008

Anticoagulation for the initial treatment of venous thromboembolism in people with cancer.

artículo científico publicado en 2018

Anticoagulation for the long term treatment of venous thromboembolism in patients with cancer

artículo científico publicado en 2008

Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer

artículo científico publicado en 2014

Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer

artículo científico publicado en 2011

Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer

artículo científico publicado en 2018

Anticoagulation for thrombosis prophylaxis in cancer patients with central venous catheters

artículo científico publicado en 2007

Aromatase inhibitors for metastatic male breast cancer: molecular, endocrine, and clinical considerations.

artículo científico

Association between AXL, Hippo Transducers, and Survival Outcomes in Male Breast Cancer ⬇️

artículo científico publicado en 2016

Association between mode of breast cancer detection and diagnosis delay

artículo científico publicado en 2009

Body Mass Index and Treatment Outcomes in Metastatic Breast Cancer Patients Treated With Eribulin.

artículo científico publicado en 2015

Body mass index and treatment outcomes following neoadjuvant therapy in women aged 45 y or younger: Evidence from a historic cohort

artículo científico publicado en 2016

Body mass index in HER2-negative metastatic breast cancer treated with first-line paclitaxel and bevacizumab.

artículo científico publicado en 2018

Body mass index modifies the relationship between γ-H2AX, a DNA damage biomarker, and pathological complete response in triple-negative breast cancer.

artículo científico publicado en 2017

Cancer mortality trends between 1988 and 2009 in the metropolitan area of Naples and Caserta, Southern Italy: Results from a joinpoint regression analysis

artículo científico publicado en 2013

Cancer patients and coronavirus disease 2019: evidence in context

artículo científico publicado en 2020

Cancer stem cells: are they responsible for treatment failure?

artículo científico publicado en 2014

Coexisting YAP expression and TP53 missense mutations delineates a molecular scenario unexpectedly associated with better survival outcomes in advanced gastric cancer

artículo científico publicado en 2018

DNA Damage and Repair Biomarkers in Cervical Cancer Patients Treated with Neoadjuvant Chemotherapy: An Exploratory Analysis

artículo científico publicado en 2016

DNA damage repair and survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy.

artículo científico publicado en 2017

Deep sequencing and pathway-focused analysis revealed multigene oncodriver signatures predicting survival outcomes in advanced colorectal cancer

artículo científico publicado en 2018

Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting

artículo científico publicado en 2019

Docetaxel, oxaliplatin, and capecitabine combination chemotherapy for metastatic gastric cancer.

artículo científico publicado en 2013

ESAS and FACT-B in eribulin-treated metastatic breast cancer patients: a multicenter, prospective and observational study

artículo científico publicado en 2017

Efficacy of chemotherapy in metastatic male breast cancer patients: a retrospective study

artículo científico publicado en 2015

Emerging biological treatments for uterine cervical carcinoma.

artículo científico publicado en 2014

Equol status modifies the association of soy intake and mammographic density in a sample of postmenopausal women

artículo científico publicado en 2008

Eribulin in Triple Negative Metastatic Breast Cancer: Critic Interpretation of Current Evidence and Projection for Future Scenarios

scientific article published on 12 October 2019

Erythrocyte membrane phospholipid composition as a biomarker of dietary fat.

artículo científico publicado en 2005

Expression of phosphorylated Hippo pathway kinases (MST1/2 and LATS1/2) in HER2-positive and triple-negative breast cancer patients treated with neoadjuvant therapy.

artículo científico publicado en 2017

Expression of the Hippo transducer TAZ in association with WNT pathway mutations impacts survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy

artículo científico publicado en 2018

Extended perioperative thromboprophylaxis in patients with cancer

artículo científico publicado en 2008

Extended perioperative thromboprophylaxis in patients with cancer. A systematic review

artículo científico publicado en 2008

FOLFIRI as a second-line therapy in patients with docetaxel-pretreated gastric cancer: a historical cohort.

artículo científico publicado en 2013

Fasting glucose and body mass index as predictors of activity in breast cancer patients treated with everolimus-exemestane: The EverExt study

artículo científico publicado en 2017

Fasting glucose and treatment outcome in breast and colorectal cancer patients treated with targeted agents: results from a historic cohort.

artículo científico publicado en 2011

Fulvestrant 500 milligrams as endocrine therapy for endocrine sensitive advanced breast cancer patients in the real world: the Ful500 prospective observational trial.

artículo científico publicado en 2017

GLUT 1 receptor expression and circulating levels of fasting glucose in high grade serous ovarian cancer.

artículo científico publicado en 2017

Gemcitabine-oxaliplatin (GEMOX) as salvage treatment in pretreated epithelial ovarian cancer patients.

artículo científico publicado en 2013

HMG-CoAR expression in male breast cancer: relationship with hormone receptors, Hippo transducers and survival outcomes ⬇️

artículo científico publicado en 2016

Highly durable response to capecitabine in patient with metastatic estrogen receptor positive breast cancer: A case report

artículo científico publicado en 2019

Hot flushes in women with breast cancer: state of the art and future perspectives

artículo científico

Immunotherapy in HER2-positive breast cancer: state of the art and future perspectives

artículo científico publicado en 2019

Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence

artículo científico publicado en 2020

Indirect Basal Metabolism Estimation in Tailoring Recombinant Human TSH Administration in Patients Affected by Differentiated Thyroid Cancer: A Hypothesis-Generating Study.

artículo científico publicado en 2018

Iodixanol versus iopromide in cancer patients: Evidence from a randomized clinical trial

artículo científico publicado en 2017

Is it time to test metformin in breast cancer prevention trials? A reply to the authors.

artículo científico publicado en 2009

Letrozole combined with gonadotropin-releasing hormone analog for metastatic male breast cancer.

artículo científico publicado en 2013

Lifetime total and beverage specific--alcohol intake and prostate cancer risk: a case-control study

artículo científico publicado en 2004

Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer

artículo científico publicado en 2014

Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer

artículo científico publicado en 2011

Low-molecular-weight heparin vs unfractionated heparin for perioperative thromboprophylaxis in patients with cancer: a systematic review and meta-analysis

artículo científico publicado en 2008

Low-molecular-weight heparins are superior to vitamin K antagonists for the long term treatment of venous thromboembolism in patients with cancer: a cochrane systematic review

artículo científico publicado en 2008

Metabolic Determinants and Anthropometric Indicators Impact Clinical-pathological Features in Epithelial Ovarian Cancer Patients.

artículo científico publicado en 2016

Metformin and breast cancer: basic knowledge in clinical context.

artículo científico

Metformin, diet and breast cancer: an avenue for chemoprevention.

artículo científico publicado en 2009

Molecular profiles of screen detected vs. symptomatic breast cancer and their impact on survival: results from a clinical series

artículo científico publicado en 2013

Mortality trend for liver cancer in a hyperendemic area of hepatitis C virus infection in southern Italy: join-point analysis and comparison with European and Italian data

artículo científico publicado en 2014

Mutations in the KEAP1-NFE2L2 Pathway Define a Molecular Subset of Rapidly Progressing Lung Adenocarcinoma

scientific article published on 16 July 2019

Neoadjuvant Chemotherapy In Triple-Negative Breast Cancer: A Multicentric Retrospective Observational Study In Real-Life Setting.

artículo científico

Neoadjuvant Sequential Docetaxel Followed by High-Dose Epirubicin in Combination With Cyclophosphamide Administered Concurrently With Trastuzumab. The DECT Trial

artículo científico publicado en 2016

Observational study of coagulation activation in early breast cancer: development of a prognostic model based on data from the real world setting.

artículo científico publicado en 2018

Oral anticoagulation for prolonging survival in patients with cancer

artículo científico publicado en 2007

Oral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation

artículo científico publicado en 2014

Oral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation

artículo científico publicado en 2014

Oral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation

artículo científico publicado en 2010

Oral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation

artículo científico publicado en 2011

Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation.

artículo científico publicado en 2017

Outcome analysis of breast cancer patients receiving breast-conserving surgery in Southern Italy

scientific article published on 01 April 2008

Outcomes of HER2-positive early breast cancer patients in the pre-trastuzumab and trastuzumab eras: a real-world multicenter observational analysis. The RETROHER study

artículo científico publicado en 2014

Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience

artículo científico publicado en 2018

Parenteral anticoagulation for prolonging survival in patients with cancer who have no other indication for anticoagulation

artículo científico publicado en 2007

Parenteral anticoagulation in ambulatory patients with cancer

artículo científico publicado en 2014

Parenteral anticoagulation in ambulatory patients with cancer.

artículo científico publicado en 2017

Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation

artículo científico publicado en 2011

Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation

artículo científico publicado en 2011

Parenteral anticoagulation may prolong the survival of patients with limited small cell lung cancer: a Cochrane systematic review

artículo científico publicado en 2008

Perinatal exposures and breast cancer risk in the Western New York Exposures and Breast Cancer (WEB) Study.

artículo científico publicado en 2006

Predictive significance of DNA damage and repair biomarkers in triple-negative breast cancer patients treated with neoadjuvant chemotherapy: An exploratory analysis

artículo científico publicado en 2015

Prognostic relevance of DNA damage and repair biomarkers in elderly patients with hormone-receptor-positive breast cancer treated with neoadjuvant hormone therapy: evidence from the real-world setting

artículo científico publicado en 2019

Reducing the risk of overdiagnosis in lung cancer: A support from molecular biology

artículo científico publicado en 2011

Reliability of urinary 6-sulfatoxymelatonin as a biomarker in breast cancer

Risk of SARS-CoV-2 infection and disease in metastatic triple-negative breast cancer patients treated with immune checkpoint inhibitors

scientific article published on 03 June 2020

Role of gonadotropin-releasing hormone analogues in metastatic male breast cancer: results from a pooled analysis ⬇️

artículo científico publicado en 2015

Targeting immune response with therapeutic vaccines in premalignant lesions and cervical cancer: hope or reality from clinical studies

scientific article published on 11 April 2016

The Hippo transducer TAZ as a biomarker of pathological complete response in HER2-positive breast cancer patients treated with trastuzumab-based neoadjuvant therapy.

artículo científico publicado en 2014

The Hippo transducers TAZ and YAP in breast cancer: oncogenic activities and clinical implications.

artículo científico

The Hippo transducers TAZ/YAP and their target CTGF in male breast cancer ⬇️

artículo científico publicado en 2016

The burden of breast cancer in Italy: mastectomies and quadrantectomies performed between 2001 and 2008 based on nationwide hospital discharge records

artículo científico publicado en 2012

The clinical significance of PD-L1 in advanced gastric cancer is dependent on ARID1A mutations and ATM expression

scientific article published on 24 April 2018

The effects of metformin on endogenous androgens and SHBG in women: a systematic review and meta-analysis

artículo científico publicado en 2008

Thromboprophylaxis for patients with cancer and central venous catheters: a systematic review and a meta-analysis

artículo científico publicado en 2008

Topographic expression of the Hippo transducers TAZ and YAP in triple-negative breast cancer treated with neoadjuvant chemotherapy

artículo científico publicado en 2016

Triple positive breast cancer: a distinct subtype?

artículo científico publicado en 2014

Urinary estrogen metabolites and prostate cancer: a case-control study and meta-analysis.

artículo científico publicado en 2009

Vitamin D supplementation and breast cancer prevention: a systematic review and meta-analysis of randomized clinical trials

artículo científico publicado en 2013

Wasting lives: the effects of toxic waste exposure on health. The case of Campania, Southern Italy.

artículo científico publicado en 2011

p53 status as effect modifier of the association between pre-treatment fasting glucose and breast cancer outcomes in non diabetic, HER2 positive patients treated with trastuzumab.

artículo científico publicado en 2014

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda